HBIO
HARVARD BIOSCIENCE INC
Key Financials
Operating Income
$-48580000
↓ 682.2%
Net Income
$-56700000
↓ 357.1%
Gross Profit
$49.9M
↓ 8.9%
EPS (Diluted)
$-1.28
↓ 357.1%
Revenue
$86.5M
↓ 8.1%
Total Liabilities
$66.3M
↑ 4.8%
Shareholders' Equity
$13.7M
↓ 78.3%
Total Assets
$80.1M
↓ 36.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/1/2026 | View on SEC |
| 4 | 4/1/2026 | View on SEC |
| 4 | 3/23/2026 | View on SEC |
| SCHEDULE 13D | 3/23/2026 | View on SEC |
| 4 | 3/18/2026 | View on SEC |
| 4 | 3/18/2026 | View on SEC |
| 4 | 3/17/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 10-K | 3/13/2026 | View on SEC |
| 8-K | 3/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HBIO |
| Company Name | HARVARD BIOSCIENCE INC |
| CIK | 1123494 |
| Sector | Laboratory Analytical Instruments |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 5088938999 |